Latest news with #Angle
Daily Mirror
2 days ago
- General
- Daily Mirror
Parents warned after schoolgirl is ruthlessly bullied over 'unique' name
A schoolgirl has been turned into a laughing stock after her parents gave her a 'unique' name with an incorrect spelling, promoting a warning to parents everywhere Parents have been issued a stern warning after it emerged that a young schoolgirl named Angle was being mercilessly taunted by her peers due to her 'unique' moniker. Despite teachers' efforts to halt the mockery, whispers and chuckles persist behind the girl's back. A concerned individual took to Reddit to spread awareness, revealing: "My sister (currently in college in the Netherlands) mentioned to me today that one of her classmates is named 'Angle' (pronounced Angel). She says her mother made a spelling mistake, because she doesn't speak any English, but only later found out and decided not to change it, because she liked Angle better." Tragically, the girl endures ridicule and is frequently called hoek, translating to 'corner' in Dutch. The post continued: "She is relentlessly bullied by everyone. Every time her name comes up and is being called out loud, the teachers pronounce it as it is written. I feel bad for the poor kid.." Highlighting the potential consequences of unconventional naming, the social media user implored parents to meticulously verify spellings before finalising their child's birth certificate. In response to the tale, one commenter confessed: "Once I encountered a Kristle instead of Crystal. I think about it sometimes how it reminded me of Gristle." Yet another chimed in: "Their entire lives, everyone they meet will think their parents didn't know how to spell it and tried to sound it out." The debate sparked a range of reactions, with one person commenting: "So many people picking names forget it isn't about them, it is about the small person who has to live with the name. And spell it out then explain it over and over and over and.." A third user joked: "How good a student is Angle? Is she... obtuse?". Another user pointed out: "Your sister is in college, so her classmate isn't a 'kid'. Adults can change their name, and this one would just look like a spelling error once it's done." A fellow commenter shared: "My mother-in-law used to always post about my child on Facebook writing, 'Grandma's little angle'. I still find it hilarious. As a name, it's a travesty." In England, people can change their name legally at 16, while those aged under 16 require a parent or guardian to execute the change on their behalf, and if applicable with both parents' consent. The UK saw an estimated 85,000 name changes via deed poll in 2015. The top motivations included not liking one's given name, unusual or tricky spelling, and as part of getting married or divorced. Some changed their name to give it a more English feel, others to express a new gender identity, and a few to prevent an ex-partner from finding them.
Yahoo
4 days ago
- Health
- Yahoo
Paradromics implants brain-computer interface into first human patient
June 2 (UPI) -- Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient and recorded neural activity, before removing it 10 minutes later. The surgical procedure, performed May 14 at the University of Michigan, marks the first time Paradromics has temporarily implanted its device -- called Connexus -- into a human with the goal of restoring neural signals in patients with spinal cord injuries, stroke or ALS. Until last month, the Austin-based startup had only implanted and tested the device on sheep. "We've shown in sheep that our device is best in class from a data and longevity standpoint, and now we've also shown that it's compatible with humans," Matt Angle, Paradromics founder and chief executive officer, told CNBC. Last year, Elon Musk's Neuralink became the first to implant a brain-computer interface into a human patient. Noland Arbaugh, who was paralyzed in an accident in 2016, received "the Link" implant in January 2024. Since then, Arbaugh has been using it for up to eight hours a day and is able to do a variety of digital tasks. Brain-computer interface companies Precision Neuroscience and Synchron, which is backed by Jeff Bezos and Bill Gates, have also implanted their systems into humans. While brain-computer interfaces interpret neural signals associated with movement, they do not read thoughts. Connexus, which is smaller than a dime and has 420 small electrodes, is embedded directly into the surrounding brain tissue. Paradromics' BCI records brain activity at the level of individual neurons. "By having proximity to the individual neurons, you can get the highest-quality signal," said Angle. The patient, who received last month's Connexus implant, was already undergoing neurosurgery to treat epilepsy and consented to the research, allowing doctors to temporarily implant the device into their temporal lobe. "There's a very unique opportunity when someone is undergoing a major neurosurgical procedure," said Angle. "They're going to have their skull opened up, and there's going to be a piece of brain that will be imminently removed. Under these conditions, the marginal risk of testing out a brain implant is actually very low." While Paradromics' Connexus implant is still being reviewed by regulators, research institutions such as the University of Michigan are allowed to use the devices as long as they prove there is no significant risk to the patient. "You do all of these steps, you validate the hardware, you have this really high degree of rational certainty that things are going to work," Angle said, "but still emotionally when it works and when it happens the way you expected it to, it's still very, very gratifying."
UPI
4 days ago
- Business
- UPI
Paradromics implants brain-computer interface into first human patient
Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient last month at the University of Michigan, and recorded neural activity before removing it 10 minutes later. Photo by University of Michigan June 2 (UPI) -- Paradromics, a competitor of Neuralink, announced Monday it safely implanted a brain-computer interface into a human patient and recorded neural activity, before removing it 10 minutes later. The surgical procedure, performed May 14 at the University of Michigan, marks the first time Paradromics has temporarily implanted its device -- called Connexus -- into a human with the goal of restoring neural signals in patients with spinal cord injuries, stroke or ALS. Until last month, the Austin-based startup had only implanted and tested the device on sheep. "We've shown in sheep that our device is best in class from a data and longevity standpoint, and now we've also shown that it's compatible with humans," Matt Angle, Paradromics founder and chief executive officer, told CNBC. Last year, Elon Musk's Neuralink became the first to implant a brain-computer interface into a human patient. Noland Arbaugh, who was paralyzed in an accident in 2016, received "the Link" implant in January 2024. Since then, Arbaugh has been using it for up to eight hours a day and is able to do a variety of digital tasks. Brain-computer interface companies Precision Neuroscience and Synchron, which is backed by Jeff Bezos and Bill Gates, have also implanted their systems into humans. While brain-computer interfaces interpret neural signals associated with movement, they do not read thoughts. Connexus, which is smaller than a dime and has 420 small electrodes, is embedded directly into the surrounding brain tissue. Paradromics' BCI records brain activity at the level of individual neurons. "By having proximity to the individual neurons, you can get the highest-quality signal," said Angle. The patient, who received last month's Connexus implant, was already undergoing neurosurgery to treat epilepsy and consented to the research, allowing doctors to temporarily implant the device into their temporal lobe. "There's a very unique opportunity when someone is undergoing a major neurosurgical procedure," said Angle. "They're going to have their skull opened up, and there's going to be a piece of brain that will be imminently removed. Under these conditions, the marginal risk of testing out a brain implant is actually very low." While Paradromics' Connexus implant is still being reviewed by regulators, research institutions such as the University of Michigan are allowed to use the devices as long as they prove there is no significant risk to the patient. "You do all of these steps, you validate the hardware, you have this really high degree of rational certainty that things are going to work," Angle said, "but still emotionally when it works and when it happens the way you expected it to, it's still very, very gratifying."
CNBC
4 days ago
- Business
- CNBC
Neuralink competitor Paradromics completes first human implant
Neurotech startup Paradromics on Monday announced it has implanted its brain-computer interface in a human for the first time. The procedure took place May 14 at the University of Michigan with a patient who was already undergoing neurosurgery to treat epilepsy. The company's technology was implanted and removed from the patient's brain in about 20 minutes during that surgery. Paradromics said the procedure demonstrated that its system can be safely implanted and record neural activity. It's a major milestone for the nearly 10-year-old startup, as it marks the beginning of its next chapter as a clinical-stage company. Once regulators give it the green light, Paradromics plans to kick off a clinical trial later this year that will study the long-term safety and use of its technology in humans. "We've shown in sheep that our device is best in class from a data and longevity standpoint, and now we've also shown that it's compatible with humans," Paradromics founder and CEO Matt Angle told CNBC in an interview. "That's really exciting and raises a lot of excitement for our upcoming clinical trial." A brain-computer interface, or BCI, is a system that deciphers brain signals and translates them into commands for external technologies. Paradromics' system is called the Connexus Brain-Computer Interface, and the company says it will initially help patients with severe motor impairments such as paralysis speak through a computer. Paradromics' BCI has not been cleared by the U.S. Food and Drug Administration, and it still has a long road ahead before it reaches commercialization. But for Angle, who founded the company in 2015, the procedure in May was a success, and one that was years in the making. "You do all of these steps, you validate the hardware, you have this really high degree of rational certainty that things are going to work," he said, "but still emotionally when it works and when it happens the way you expected it to, it's still very, very gratifying." Though Paradromics' BCI has not been officially cleared for use by regulators, organizations like the University of Michigan can use new devices for research as long as they can demonstrate that there is not a significant risk to patients. Dr. Oren Sagher, professor of neurosurgery at the University of Michigan, oversaw the traditional clinical component of the procedure in May. Dr. Matthew Willsey, assistant professor of neurosurgery and biomedical engineering at the University of Michigan, led the research component, including the placement of Paradromics' device. BCIs have been studied in academia for decades, and several other startups, including Elon Musk's Neuralink, are developing their own systems. "It's absolutely thrilling," Willsey said in an interview. "It's motivating, and this is the kind of thing that helps me get up in the morning and go to work." Each company's BCI is slightly different, but Paradromics is designing a BCI that can record brain activity at the level of individual neurons. Angle compared this approach to placing microphones inside vs. outside a stadium. Inside a stadium, microphones would capture more detail, such as individual conversations. Outside a stadium, microphones would only capture the roar of the crowd, he said. Other prominent BCI companies include Synchron, which is backed by Jeff Bezos and Bill Gates, and Precision Neuroscience. Both have implanted their systems in humans. Paradromics has raised nearly $100 million as of February, according to PitchBook. The company announced a strategic partnership with Saudi Arabia's Neom in February, but declined to disclose the investment amount. "The last demonstration stuff has been shown, and we're really excited about the clinical trial that's coming up," Angle said.
Time of India
23-05-2025
- Business
- Time of India
EDC simplifies CMRY scheme, expands access
Panaji: In a major policy shift aimed at widening access and accelerating disbursement, the Economic Development Corporation (EDC) of Goa announced significant simplifications to the Chief Minister's Rojgar Yojana (CMRY). The move, announced on Friday by EDC managing director B S Pai Angle, aims to promote entrepreneurship among Goans. 'We have removed all the hurdles existing in the CMRY scheme. It has now been greatly simplified,' Angle said, adding that officers have been deployed to panchayats across Goa since April 15 to spread information about the reforms in the scheme. 'We've already covered 50% of the panchayats and expect to reach the remaining soon,' said Angle. Among the key reforms, the age limit for applicants was raised from 42 to 50 years, with the condition that the loan repayment period must be completed by the age of 60. The scheme also removed the earlier income ceiling of Rs 10 lakh for eligibility, making it accessible not just to first-time entrepreneurs but also to existing business owners. Also, applications will now be considered even if the applicant has an outstanding loan with another bank. by Taboola by Taboola Sponsored Links Sponsored Links Promoted Links Promoted Links You May Like Switch to UnionBank Rewards Card UnionBank Credit Card Apply Now Undo Angle said the EDC streamlined the processing system to ensure that loan sanction and disbursement are completed within two to three weeks. EDC disbursed over Rs 300 crore to more than 8,000 beneficiaries under the scheme in recent years, with 200 to 250 new applicants receiving sanctions this year alone. Angle acknowledged that the COVID-19 pandemic led to a spike in business failures, resulting in a default rate of around 10%. To address this, EDC is now offering structured entrepreneurial training along with financial support. 'Finance and skilling alone aren't enough. Our youth also need support in areas like compliance, legal issues, and business management,' he said.
